Yahoo
Canadian Sec - Delayed Quote CAD

Vireo Growth Inc. (VREO.CN)

9.40 -0.81 (-7.93%)
At close: November 5 at 3:59:59 PM EST
Chart Range Bar
Loading chart for VREO.CN
  • Previous Close 10.21
  • Open 10.15
  • Bid 9.40 x --
  • Ask 9.83 x --
  • Day's Range 9.36 - 10.15
  • 52 Week Range 9.36 - 30.00
  • Volume 41,212
  • Avg. Volume 18,530
  • Market Cap (intraday) 491.77M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) --
  • EPS (TTM) -2.35
  • Earnings Date Nov 10, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

vireogrowth.com

520

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VREO.CN
60.83%
S&P/TSX Composite index (^GSPTSE)
11.73%

1-Year Return

VREO.CN
62.70%
S&P/TSX Composite index (^GSPTSE)
19.57%

3-Year Return

VREO.CN
20.51%
S&P/TSX Composite index (^GSPTSE)
79.60%

5-Year Return

VREO.CN
81.46%
S&P/TSX Composite index (^GSPTSE)
65.95%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 209.3M
Earnings -100k
Profit Margin -0.05%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

0
50M
100M
150M
200M
-0.0%
-0.0%
-0.0%
-0.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.12%

  • Return on Assets (ttm)

    2.28%

  • Return on Equity (ttm)

    -18.88%

  • Revenue (ttm)

    511.67M

  • Net Income Avi to Common (ttm)

    -67.11M

  • Diluted EPS (ttm)

    -2.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.1M

  • Total Debt/Equity (mrq)

    109.79%

  • Levered Free Cash Flow (ttm)

    -42.95M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: